CIAM
TYRA icon

Caitong International Asset Management’s Tyra Biosciences TYRA Stock Holding History

Caitong International Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.3K Buy
1,918
+27
+1% +$893 0.01% 668
2026
Q1 		$72.4K Sell
1,891
-1,106
-37% -$35.8K 0.01% 676
2025
Q4 		$78.8K Buy
+2,997
New +$55K 0.02% 534
2025
Q3 		– Sell
-569
Closed -$5.45K – 2532
2025
Q2 		$5.45K Buy
569
+66
+13% +$627 ﹤0.01% 984
2025
Q1 		$4.68K Buy
+503
New +$6.51K ﹤0.01% 1040

Other funds holding TYRA

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Caitong International Asset Management's TYRA Position: Q2 2026 in Review

Caitong International Asset Management increased its Tyra Biosciences (TYRA) stake by 1.4% in Q2 2026, buying an estimated $893 and bringing the position to 1,918 shares worth $61.3K. The position accounts for 0.01% of the portfolio, ranked #668.

Caitong International Asset Management first reported a position in TYRA in Q1 2025 and has held it in 5 quarters since. The position peaked at $78.8K in Q4 2025. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Caitong International Asset Management held 1,918 shares of Tyra Biosciences worth $61.3K as of Q2 2026.
  • Caitong International Asset Management bought 27 Tyra Biosciences shares in Q2 2026, an estimated $893.
  • Tyra Biosciences made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #668 holding.
  • Caitong International Asset Management first reported a position in Tyra Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Tyra Biosciences position peaked at $78.8K in Q4 2025.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.